GM24310
Fibroblast from Skin, Skin
Description:
SMITH-MAGENIS SYNDROME; SMS
|
Repository
|
NIGMS Human Genetic Cell Repository
|
| Subcollection |
Chromosome Abnormalities
PIGI Consented Sample |
|
Biopsy Source
|
Skin
|
|
Cell Type
|
Fibroblast
|
|
Tissue Type
|
Skin
|
|
Transformant
|
Untransformed
|
|
Sample Source
|
Fibroblast from Skin, Skin
|
|
Race
|
White
|
|
Ethnicity
|
Hispanic/Latino
|
|
Ethnicity
|
MEXICAN/GERMAN/IRISH
|
|
Country of Origin
|
USA
|
|
Family Member
|
1
|
|
Family History
|
N
|
|
Relation to Proband
|
proband
|
|
Confirmation
|
Karyotypic analysis and In situ hybridization
|
|
ISCN
|
46,XY,del(17)(p11.2p11.2).arr[hg19] 17p11.2(16769800-20354018)x1,17q12(34443799-34629684)x1
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
|
Remarks
|
|
| PDL at Freeze |
3.78 |
| Passage Frozen |
2 |
| |
| IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
| |
| Remarks |
Clinically affected; symptom onset at 1 year of age; diagnosed at 14 months; dysmorphic facial features; brachycephaly; brachydactyly; short stature-growth hormone deficiency; strabismus; sensorineural hearing defect; hypotonia; decreased pain sensitivity; hoarse voice; pulmonic valve stenosis; small but normally functioning kidneys; fine motor delay; gross motor delay; speech delay; intellectual disability; sleep disturbances; repetitive behaviors; self-injurious behaviors; normal MRI; medications include growth hormone; unaffected mother is GM24273 (Lymph) and GM24309 (Fibro). |
| Cumulative PDL at Freeze |
3.78 |
| Passage Frozen |
2 |
| Split Ratio |
1:3 |
| Temperature |
37 C |
| Percent CO2 |
5% |
| Percent O2 |
AMBIENT |
| Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
| Serum |
15% fetal bovine serum Not inactivated |
| Supplement |
- |
|
|